EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer

Peiyu Zheng, Jinchun Liu

Current Oncology · 2023

DOI: 10.3390/curroncol30010086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Peiyu Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer is one of the most common gastrointestinal cancers. Early diagnosis can improve the 5-year survival rate. This study aimed to evaluate the cost-effectiveness of Helicobacter pylori (Hp) and a new gastric cancer screening scoring system (NGCS) in areas with a high incidence of gastric cancer. A decision-analytic Markov model was constructed based on the theory and method of cost-effectiveness analysis, which included three decisions: no screening, Hp screening, and NGCS screening. The uncertainty of each parameter in the model was determined using a one-way sensitivity analysis and probability sensitivity analysis. The results of the cost-effectiveness analysis revealed that the application of the NGCS had the highest cost-effectiveness, while the one-way sensitivity analysis revealed that the probability of intestinal metaplasia progression to dysplasia had the most significant effect on the incremental cost-effectiveness ratio. The probability sensitivity analysis concluded that the result of the NGCS having the highest cost-effectiveness was stable. Although the application of the NGCS will require upfront screening costs, it can significantly improve the detection rate of early gastric cancer and save the consequent long-term healthcare costs. It is practicable and can be popularized in China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHelicobacter pyloriHelicobacter InfectionsHumansCost-Effectiveness AnalysisCost-Benefit AnalysisMarkov ChainsEarly Detection of Cancer

Stichwörter der Autor:innen

Hpcost-effectiveness analysisgastric cancernew gastric cancer screening scoring system

Autor:innen und Institutionen

  • Graduate School, Shanxi Medical University, Taiyuan 030001, China.
  • Department of Gastroenterology, The First Hospital of Shanxi Medical University, Taiyuan 030001, China.

Förderung

  • Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province, China

Zitieren

APA

Zheng, P., & Liu, J. (2023). Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer. Current Oncology. https://doi.org/10.3390/curroncol30010086

Vancouver

Zheng P, Liu J. Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer. Current Oncology. 2023. doi:10.3390/curroncol30010086

BibTeX
@article{Zheng2023,
  author = {Zheng, Peiyu and Liu, Jinchun},
  title = {Cost-Effectiveness Analysis of Hp and New Gastric Cancer Screening Scoring System for Screening and Prevention of Gastric Cancer},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30010086}
}
Kostenlos starten →